Al. Bittencourt et al., CLINICOPATHOLOGICAL ASPECTS OF HTLV-1 POSITIVE AND NEGATIVE CUTANEOUST-CELL LYMPHOMA, EJD. European journal of dermatology, 7(4), 1997, pp. 283-289
The clinico-pathological and immunohistochemical features of 17 cases
of HTLV-1(+) cutaneous T-cell lymphoma (CTCL) are compared with 17 cas
es of HTLV-1(-) CTCL. All patients were from the same geographical are
a in Northeastern Brazil, an area endemic for HTLV-1(+) infection. In
all patients, cutaneous lesions were the first clinical manifestation
of disease. In both the HTLV-1(+) and the HTLV-1(-) groups, 12 patient
s had pleomorphic lymphoma and 5 had mycosis fungoides (MF). Clinical
subtypes in the HTLV-1(+) group included five cases of acute, two case
s of chronic, nine cases of smoldering and one case of lymphoma type a
dult T-cell leukemia/lymphoma (ATL). A few clinical differences were n
oticed between the two groups: a marked predominance of black, mulatto
and male subjects, a more aggressive course and a higher frequency of
erythroderma and disseminated skin lesions in the HTLV-1(+) patients.
However, around 40% of the HTLV-1(+) patients had an indolent course
of disease with an evolution of up to 20 years. No specific histopatho
logical features that could allow a distinction between HTLV-1(+) and
HTLV-1(-) lymphomas were found. No significant differences were observ
ed between the two groups concerning the intensity of cellular pleomor
phism, cellular size, epidermotropism, frequency and size of Pautrier'
s abscesses, fibrosis of the papillary derma, and eosinophilic infiltr
ate. In two HTLV-1(+) lymphomas, atypical multinucleated giant cells w
ere present. Considering the present knowledge concerning ATL and CTCL
, it seems more appropriate to designate CTCL as HTLV-1(+) or HTLV-1(-
) and morphologically as pleomorphic, MF, large cell anaplastic lympho
ma or other histological types. The use of the terminology, cutaneous
type of ATL, is confusing since there are HTLV-1(+) cutaneous lymphoma
s with clinical and histological features distinctly different from AT
L.